VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $389,000 | -95.7% | 3,825 | -92.5% | 0.02% | -96.0% |
Q3 2015 | $9,112,000 | +4.4% | 51,082 | +30.0% | 0.49% | +13.8% |
Q2 2015 | $8,730,000 | -15.4% | 39,298 | -24.3% | 0.43% | -15.9% |
Q1 2015 | $10,316,000 | +8.9% | 51,940 | -21.5% | 0.52% | +10.0% |
Q4 2014 | $9,470,000 | +9.7% | 66,177 | +0.5% | 0.47% | +6.1% |
Q3 2014 | $8,636,000 | +9.1% | 65,827 | +4.9% | 0.44% | +8.6% |
Q2 2014 | $7,913,000 | – | 62,744 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |